This site is intended for healthcare professionals only
LoginRegister
ED attaches Telangana pharma firm assets for illegal export of drugsED attaches Telangana pharma firm assets for illegal export of drugs
Action taken against 694 manufacturing units since 2022: MinisterFolic Acid Dosage Mislabeling: CDSCO Panel Proposes Urgent Correction in Drug Rules
USFDA issues 2 observattions for Cipla arm Mahape facilityUSFDA issues 2 observations for Cipla arm Mahape facility
Govt extends deadline for submitting applications under PLI SchemeCipla bags USFDA nod for chronic myeloid leukemia drug Nilotinib
Dr Reddys Gets CDSCO Panel Nod To Import, Market Saccharomyces Boulardii, BE, CT WaivedDr Reddy's Laboratories Gets CDSCO Panel Nod To Study Semaglutide in Type 2 Diabetes Mellitus
CureVac announces resolution of patent litigation with Pfizer/BioNTechDrug price fixation: Sandoz to pay $275 million to settle case
Siemens sells 2 percent stake in Siemens HealthineersSiemens sells 2 percent stake in Siemens Healthineers, raises around USD 1.5 billion
AstraZeneca Imfinzi gets USFDA priority reviewUSFDA issues 7 minor observations for Orchid Pharma Alathur facility
Illegally stocked drugs worth Rs 6.70 lakhs seizedTelangana: Illegally stocked drugs worth Rs 6.70 lakhs seized from unlicensed godown
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoidUSFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid
Boehringer, Click Therapeutics investigational prescription digital therapeutic meets primary endpoint in study for schizophreniaBoehringer Ingelheim gets USFDA priority review for Zongertinib for HER2 (ERBB2)-mutant advanced...
Unichem Labs Roha facility gets 3 USFDA observationsAurobindo Pharma USA New Jersey warehouse gets USFDA OAI status
X